Cargando…
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
Autores principales: | Sasa, Keita, Saito, Tsuyoshi, Kurihara, Taisei, Hasegawa, Nobuhiko, Sano, Kei, Kubota, Daisuke, Akaike, Keisuke, Okubo, Taketo, Hayashi, Takuo, Takagi, Tatsuya, Yao, Takashi, Ishijima, Muneaki, Suehara, Yoshiyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956751/ https://www.ncbi.nlm.nih.gov/pubmed/35334007 http://dx.doi.org/10.1007/s12672-022-00481-6 |
Ejemplares similares
-
RETRACTED ARTICLE: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2021) -
Establishment of Rapid and Accurate Screening System for Molecular Target Therapy of Osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing’s sarcoma
por: Tanabe, Yu, et al.
Publicado: (2018) -
Nanostring-based screening for tyrosine kinase fusions in inflammatory myofibroblastic tumors
por: Kurihara, Taisei, et al.
Publicado: (2020) -
Novel mechanism of enhancing IRE1α-XBP1 signalling via the PERK-ATF4 pathway
por: Tsuru, Akio, et al.
Publicado: (2016)